ANNX - Annexon spikes after updating late-stage results for lead asset against GBS
2024-06-26 07:40:05 ET
More on Annexon Biosciences
- Annexon: Complement Inhibition Of GBS Only The Beginning With Strong Tech In Place
- Annexon: Unforced Error Sullies Prospects
- Biggest stock movers today: BBWI, GME, HQY, and more
- Annexon spikes as lead asset hits main goal in late-stage study
- Seeking Alpha’s Quant Rating on Annexon Biosciences